Design of phase II non-inferiority trials
With the development of inexpensive treatment regimens and less invasive surgical procedures, we are confronted with non-inferiority study objectives. A non-inferiority phase III trial requires a roughly four times larger sample size than that of a similar standard superiority trial. Because of the...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Contemporary Clinical Trials Communications |
Online Access: | http://www.sciencedirect.com/science/article/pii/S245186541630134X |
id |
doaj-90e8fc3f7c1645a9b51efaf22c02eff4 |
---|---|
record_format |
Article |
spelling |
doaj-90e8fc3f7c1645a9b51efaf22c02eff42020-11-24T20:57:08ZengElsevierContemporary Clinical Trials Communications2451-86542017-09-0172327Design of phase II non-inferiority trialsSin-Ho Jung0Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USAWith the development of inexpensive treatment regimens and less invasive surgical procedures, we are confronted with non-inferiority study objectives. A non-inferiority phase III trial requires a roughly four times larger sample size than that of a similar standard superiority trial. Because of the large required sample size, we often face feasibility issues to open a non-inferiority trial. Furthermore, due to lack of phase II non-inferiority trial design methods, we do not have an opportunity to investigate the efficacy of the experimental therapy through a phase II trial. As a result, we often fail to open a non-inferiority phase III trial and a large number of non-inferiority clinical questions still remain unanswered. In this paper, we want to develop some designs for non-inferiority randomized phase II trials with feasible sample sizes. At first, we review a design method for non-inferiority phase III trials. Subsequently, we propose three different designs for non-inferiority phase II trials that can be used under different settings. Each method is demonstrated with examples. Each of the proposed design methods is shown to require a reasonable sample size for non-inferiority phase II trials. The three different non-inferiority phase II trial designs are used under different settings, but require similar sample sizes that are typical for phase II trials. Keywords: Binary outcome, Non-inferiority margin, Phase II/III trials, Randomized phase II trials, Sample size calculation, Survival outcomehttp://www.sciencedirect.com/science/article/pii/S245186541630134X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sin-Ho Jung |
spellingShingle |
Sin-Ho Jung Design of phase II non-inferiority trials Contemporary Clinical Trials Communications |
author_facet |
Sin-Ho Jung |
author_sort |
Sin-Ho Jung |
title |
Design of phase II non-inferiority trials |
title_short |
Design of phase II non-inferiority trials |
title_full |
Design of phase II non-inferiority trials |
title_fullStr |
Design of phase II non-inferiority trials |
title_full_unstemmed |
Design of phase II non-inferiority trials |
title_sort |
design of phase ii non-inferiority trials |
publisher |
Elsevier |
series |
Contemporary Clinical Trials Communications |
issn |
2451-8654 |
publishDate |
2017-09-01 |
description |
With the development of inexpensive treatment regimens and less invasive surgical procedures, we are confronted with non-inferiority study objectives. A non-inferiority phase III trial requires a roughly four times larger sample size than that of a similar standard superiority trial. Because of the large required sample size, we often face feasibility issues to open a non-inferiority trial. Furthermore, due to lack of phase II non-inferiority trial design methods, we do not have an opportunity to investigate the efficacy of the experimental therapy through a phase II trial. As a result, we often fail to open a non-inferiority phase III trial and a large number of non-inferiority clinical questions still remain unanswered. In this paper, we want to develop some designs for non-inferiority randomized phase II trials with feasible sample sizes. At first, we review a design method for non-inferiority phase III trials. Subsequently, we propose three different designs for non-inferiority phase II trials that can be used under different settings. Each method is demonstrated with examples. Each of the proposed design methods is shown to require a reasonable sample size for non-inferiority phase II trials. The three different non-inferiority phase II trial designs are used under different settings, but require similar sample sizes that are typical for phase II trials. Keywords: Binary outcome, Non-inferiority margin, Phase II/III trials, Randomized phase II trials, Sample size calculation, Survival outcome |
url |
http://www.sciencedirect.com/science/article/pii/S245186541630134X |
work_keys_str_mv |
AT sinhojung designofphaseiinoninferioritytrials |
_version_ |
1716788737039400960 |